ALLOHealthcareSmall-Cap
Allogene Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Allogene Therapeutics, Inc. (ALLO), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are ALLO insiders buying or selling?
Allogene Therapeutics, Inc. insiders reported 11 open-market buys ($27.8M) and 87 sells ($147.5M) across 98 Form 4 filings — a net selling position of $119.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Apr 23, 2026)
Total Form 4 filings
98
SEC EDGAR
Insider filers
19
Insider buys (11)
$27.8M
Insider sells (87)
$147.5M
Insider sentiment
Net sellingNet insider flow of $119.6M in net selling.
Recent ALLO insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 23, 2026 | Annie Yoshiyama | SVP, Finance | Sale | 9.6K | $2.31 | $22.1K |
| Apr 2, 2026 | Benjamin Machinas Beneski | SVP, Chief Technical Officer | Sale | 2.9K | $2.50 | $7.2K |
| Mar 18, 2026 | Benjamin Machinas Beneski | SVP, Chief Technical Officer | Sale | 4.8K | $2.47 | $11.9K |
| Mar 18, 2026 | Chang David D | President and CEO | Sale | 47.8K | $2.47 | $118.0K |
| Mar 4, 2026 | Benjamin Machinas Beneski | SVP, Chief Technical Officer | Sale | 7.1K | $2.60 | $18.5K |
| Feb 4, 2026 | Benjamin Machinas Beneski | SVP, Chief Technical Officer | Sale | 7.5K | $1.73 | $13.1K |
| Feb 4, 2026 | Chang David D | President and CEO | Sale | 95.3K | $1.80 | $171.5K |
| Feb 4, 2026 | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Sale | 24.0K | $1.76 | $42.2K |
| Feb 4, 2026 | Earl Martin Douglas | SVP, General Counsel | Sale | 22.9K | $1.76 | $40.3K |
| Feb 4, 2026 | Annie Yoshiyama | SVP, Finance | Sale | 4.2K | $1.72 | $7.2K |
| Feb 4, 2026 | Zachary Roberts | EVP of R&D | Sale | 35.7K | $1.77 | $63.2K |
| Jan 23, 2026 | Zachary Roberts | EVP of R&D | Sale | 26.3K | $1.56 | $41.0K |
| Nov 19, 2025 | Benjamin Machinas Beneski | SVP, Chief Technical Officer | Sale | 786 | $1.22 | $958.92 |
| Oct 23, 2025 | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Sale | 36.7K | $1.26 | $46.2K |
| Jun 12, 2025 | Deborah M. Messemer | Director | Sale | 36.9K | $1.42 | $52.4K |
| Apr 23, 2025 | Annie Yoshiyama | SVP, Finance | Sale | 9.6K | $1.41 | $13.5K |
| Mar 18, 2025 | Chang David D | President and CEO | Sale | 46.7K | $1.96 | $91.5K |
| Mar 18, 2025 | Benjamin Machinas Beneski | SVP, Chief Technical Officer | Sale | 5.5K | $1.98 | $10.8K |
| Feb 20, 2025 | Deborah M. Messemer | Director | Sale | 13.3K | $2.43 | $32.4K |
| Feb 5, 2025 | Earl Martin Douglas | SVP, General Counsel | Sale | 6.4K | $1.71 | $11.0K |
| Feb 5, 2025 | Geoffrey M. Parker | CHIEF FINANCIAL OFFICER | Sale | 4.4K | $1.73 | $7.5K |
| Feb 5, 2025 | Timothy L. Moore | Chief Technical Officer | Sale | 14.7K | $1.71 | $25.2K |
| Feb 5, 2025 | Chang David D | President and CEO | Sale | 46.0K | $1.68 | $77.3K |
| Feb 5, 2025 | Zachary Roberts | EVP of R&D | Sale | 18.8K | $1.70 | $32.0K |
| Jan 23, 2025 | Zachary Roberts | EVP of R&D | Sale | 27.2K | $1.78 | $48.4K |
Showing the 25 most recent of 98 Form 4 filings for Allogene Therapeutics, Inc..
Most active ALLO insiders
- Veer Bhavnagri15 filings
- Alison Moore9 filings
- Rafael Amado9 filings
- Chang David D8 filings
- David Bonderman8 filings
Ask anything about ALLO insider activity
Use Trabud's AI agent to query Allogene Therapeutics, Inc.'s Form 4 history in plain English — "Show me ALLO CEO purchases this year" or compare it against any other ticker.
Open the AI agentALLO insider trading FAQ
Are Allogene Therapeutics, Inc. insiders buying or selling?
Across 98 SEC Form 4 filings, Allogene Therapeutics, Inc. (ALLO) insiders reported 11 open-market purchases totaling $27.8M and 87 sales totaling $147.5M. That is a net selling position of $119.6M.
How many insiders trade ALLO stock?
19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Allogene Therapeutics, Inc.. The most recent filing was accepted on Apr 23, 2026.
Where does Trabud get ALLO insider trading data?
All ALLO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.